Dolutegravir + Lamivudine Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 50 mg / 300 mg
Reference Brands: Dovato(EU & US)
Category: Anti Viral
Dolutegravir + Lamivudine is available in Tablet and strengths such as 50 mg / 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Dolutegravir + Lamivudine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Dolutegravir + Lamivudine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Dolutegravir + Lamivudine is a fixed-dose combination antiretroviral medication used to treat HIV-1 infection in adults and adolescents. This two-drug regimen combines Dolutegravir, an integrase strand transfer inhibitor (INSTI), and Lamivudine, a nucleoside reverse transcriptase inhibitor (NRTI), to effectively suppress viral replication. Marketed under the brand name Dovato, it offers once-daily oral dosing with a simplified regimen, reducing pill burden. Approved by the US FDA and EMA, this dual therapy is recommended for treatment-naïve patients with no resistance to either drug. Dolutegravir + Lamivudine is known for its high efficacy, tolerability, and minimal side effects, supporting long-term HIV manageme
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Enfuvirtide Acetate
Strength:
90 mg/vial
Form: Injection
Reference Brands: Fuzeon (USA/EU)
View Details
Etravirine
Strength:
25 mg, 100 mg, 200 mg
Form: Tablets
Reference Brands: Intelence (USA), Intelence (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
